Components of Goutengsan in Rat Plasma by Microdialysis Sampling and Its Protection on A[beta]1-42-Induced PC12 Cells Injury

• Published in: Evidence-based complementary and alternative medicine Vol. 2017
• Main Authors: Hou-Cai, Huang, Chun-Fei, Wang, Jun-Fei Gu, Chen, Juan, Xue-Feng, Hou, Rong-Ling, Zhong, Xia, Zhi, Zhao, Di, Yang, Nan, Wang, Jing, Xiao-Bin, Tan, Xiao-Bin, Jia, Liu-Qing, Di, Zi-Bo Dong, Liang, Feng
• Format: Journal Article
• Language: English
• Published: New York Hindawi Limited 01-01-2017
• Subjects: Acids; Alzheimer's disease; Apoptosis; Chinese medicine; Pharmacy; Plasma; Studies; United States > US; China
• ISSN: 1741-427X; 1741-4288
• DOI: 10.1155/2017/7593027

Goutengsan, a Chinese herbal formula, potential protection on Alzheimer's disease (AD) has been less reported. In current study, we investigated the protection of Goutengsan on Aβ1-42-induced pheochromocytoma-derived cells (PC12). Furthermore, the components from Goutengsan in rat plasma were identified by microdialysis (MD) for in vivo sampling. Meanwhile, the protection of components identified was also verified. At last, we found that Goutengsan has a potential protective effect on Aβ1-42-induced PC12 cells via reducing cells damage and increasing cells vitality as well as six components (pachymic acid, liquiritin, rhynchophylline, isorhynchophylline, corynoxeine, and isocorynoxeine) which may be effective components. This study helps to understand the treatment of Goutengsan for AD and would facilitate the clinical and further studies for this formula.